Healthcare -
Biotechnology - NASDAQ - US
$ 13.25
5.16 %
$ 192 M
Market Cap
0.11
P/E
INBX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities INBX - Inhibrx Biosciences, Inc.
202 M
LAST VALUE
55.27%
2 YEAR CAGR
72.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR